title: [Autoimmune endocrinopathies induced by immunomodulating antibodies in the treatment of cancer].
authors: Unidad de Neuroendocrinología y Tumores Endocrinos, Servicio de Endocrinología y Nutrición, Hospital Ramón y Cajal, Madrid, España. Electronic address: piglo65@gmail.com.
authors: Pedro
authors: P
authors: Iglesias
authors: Servicio de Oncología Médica, Hospital Ramón y Cajal, Madrid, España.
authors: Ainara
authors: A
authors: Soria
authors: Unidad de Neuroendocrinología y Tumores Endocrinos, Servicio de Endocrinología y Nutrición, Hospital Ramón y Cajal, Madrid, España; Departamento de Medicina, Universidad de Alcalá de Henares, Alcalá de Henares, Madrid, España.
authors: Juan José
authors: JJ
authors: Díez
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000139:chemically induced*; D004700:Endocrine System Diseases / Q000139:chemically induced*; D006801:Humans; D056747:Immunomodulation; D000074324:Ipilimumab; D008545:Melanoma / Q000188:drug therapy* / Q000556:secondary*; D000077594:Nivolumab; D012878:Skin Neoplasms / Q000473:pathology*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000074324:Ipilimumab; D000077594:Nivolumab; C582435:pembrolizumab